• Next generation pan-cancer blood proteome profiling using proximity extension assay

    The presentation will describe a novel strategy to explore the proteome signature by comprehensive analysis of protein levels using a pan-cancer approach of patients representing the major cancer types. Plasma profiles of 1,463 proteins from more than 1,500 cancer patients representing altogether 12 common cancer types were measured in minute amounts of blood plasma collected at the time of diagnosis and before treatment. AI-based disease prediction models allowed for the identification of a set of proteins associated with each of the analyzed cancers. By combining the results from all cancer types, a panel of proteins suitable for the identification of all individual cancer types was defined. The results are presented in a new open access Human Disease Blood Atlas.

    Speaker

    MicrosoftTeams-image (2)

    Mathias Uhlén, PhD

    Professor, Science for Life Laboratory and Albanova University Center Royal Institute of Technology (KTH) SE-106 91 Stockholm, Sweden

    Other upcoming events

    3

    Feb -

    1

    May

    On-demand webinar in cardiovascular disease

    13

    Mar -

    13

    Jul

    Next generation pan-cancer blood proteome profiling using proximity extension assay

    4

    Apr

    Providence Hospital Seminar

    5

    Apr

    adMare BioInnovations Lunch and Seminar

    6

    Apr

    Empowering genomics with proteomics

    14

    Apr -

    19

    Apr

    AACR Annual Meeting 2023

    17

    Apr

    X-Omics Festival 2023

    27

    Apr

    Empowering Genomics With Proteomics: The Advantages of Adding Protein-Level Data

    10

    Jun -

    13

    Jun

    The European Human Genetics Conference (ESHG)

    12

    Jun -

    15

    Jun

    European Association for Cancer Research (EACR)

    2947

    Biomarker assays

    ~881 million

    Protein data points generated

    1196

    Publications listed on website

    Contact us!